-
Brainsway (BWAY) PT Lowered to $15 at H.C. Wainwright
-
BrainsWay Ltd. (BWAY) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY26 Revenue Guidance
-
BrainsWay invests $1 million in Canadian mental health provider
-
Cigna unit eliminates prior authorization for brain stimulation therapy
-
BrainsWay changes ADS-to-ordinary share ratio from 2-to-1 to 1-to-1
-
Brainsway (BWAY) PT Raised to $30 at H.C. Wainwright
-
Highmark drafts coverage policy for BrainsWay accelerated depression treatment
-
Optum expands coverage for BrainsWay depression treatment to adolescents
-
Brainsway (BWAY) PT Raised to $24 at H.C. Wainwright
-
BrainsWay gets FDA clearance for depression treatment in teens
-
BrainsWay Ltd. (BWAY) Misses Q4 EPS by 1c; offers guidance
-
BrainsWay invests in two additional US mental health providers
-
BrainsWay gets FDA clearance for accelerated depression treatment protocol
-
H.C. Wainwright Reiterates Buy Rating on Brainsway (BWAY)
-
BrainsWay invests $2.3 million in Colorado mental health clinic operator
-
Brainsway (BWAY) PT Raised to $17 at H.C. Wainwright
-
BrainsWay Ltd. (BWAY) Tops Q3 EPS by 2c
-
H.C. Wainwright Reiterates Buy Rating on Brainsway (BWAY)
-
Brainsway Ltd. (BWAY) Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for MDD
-
H.C. Wainwright Reiterates Buy Rating on Brainsway (BWAY)
-
Brainsway Ltd. (BWAY) Announces $5M Minority-Stake Investment in Stella MSO, LLC
-
H.C. Wainwright Reiterates Buy Rating on Brainsway (BWAY)
-
BrainsWay Ltd. (BWAY) Reports In-Line Q2 EPS ; Offers Guidance
-
North Carolina Passes House Bill 152, Mandates Health benefit Plans must cover TMS
-
BrainsWay Ltd. (BWAY) Tops Q1 EPS by 2c ; Offers Guidance
-
H.C. Wainwright Reiterates Buy Rating on Brainsway (BWAY)
-
Brainsway (BWAY) Reports Positive Independent Pilot Data on Accelerated Deep TMS Treatment of Alcohol Use Disorder
-
BrainsWay Ltd. (BWAY) Tops Q3 EPS by 1c ; Offers Guidance
-
H.C. Wainwright Reiterates Buy Rating on Brainsway (BWAY)
-
Brainsway (BWAY) Further Penetrates East Asia with Placement of 15 Additional Deep TMS™ Systems in Taiwan and South Korea
-
Brainsway Ltd. (BWAY) Announces $20M Private Placement
-
H.C. Wainwright Reiterates Buy Rating on Brainsway (BWAY)
-
Brainsway (BWAY): Israel Ministry of Defense Clears Deep TMS for PTSD Reimbursement at Israeli Hospitals
-
Brainsway Ltd. (BWAY) Appoints Richard A. Bermudes as Chief Medical Officer
-
Brainsway (BWAY) PT Raised to $16 at H.C. Wainwright
-
BrainsWay Ltd. (BWAY) Tops Q2 EPS by 2c ; Offers Guidance
-
Brainsway (BWAY) Expands Global Imprint with Exclusive Multi-Year Distribution Agreement in Canada

